Cerus Corp. (NASDAQ:CERS) shares were up 2.1% during trading on Monday . The company traded as high as $6.83 and last traded at $6.71, with a volume of 760,079 shares traded. The stock had previously closed at $6.57.

A number of research analysts have recently commented on CERS shares. BTIG Research reissued a “buy” rating and set a $10.00 target price (up from $8.00) on shares of Cerus Corp. in a research report on Friday, April 22nd. Cantor Fitzgerald reissued a “buy” rating and set a $9.00 target price on shares of Cerus Corp. in a research report on Thursday, July 7th. Robert W. Baird reissued an “outperform” rating and set a $9.00 target price on shares of Cerus Corp. in a research report on Wednesday, June 22nd. Finally, FBR & Co reissued a “buy” rating on shares of Cerus Corp. in a research report on Monday, July 11th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Cerus Corp. presently has an average rating of “Buy” and an average target price of $8.90.

The stock’s 50 day moving average is $6.22 and its 200-day moving average is $5.82. The company’s market cap is $676.37 million.

Cerus Corp. (NASDAQ:CERS) last issued its earnings results on Tuesday, May 3rd. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.16) by $0.01. The firm earned $7.60 million during the quarter, compared to the consensus estimate of $8.29 million. Cerus Corp.’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same quarter last year, the company earned ($0.17) EPS. Equities analysts predict that Cerus Corp. will post ($0.65) EPS for the current fiscal year.

Other institutional investors have recently added to or reduced their stakes in the company. California State Teachers Retirement System increased its position in Cerus Corp. by 1.8% in the fourth quarter. California State Teachers Retirement System now owns 176,709 shares of the company’s stock worth $1,117,000 after buying an additional 3,126 shares in the last quarter. Stephens Inc. AR increased its position in Cerus Corp. by 11.3% in the fourth quarter. Stephens Inc. AR now owns 1,112,665 shares of the company’s stock worth $7,032,000 after buying an additional 113,238 shares in the last quarter. Rail Splitter Capital Management LLC increased its position in Cerus Corp. by 19.0% in the fourth quarter. Rail Splitter Capital Management LLC now owns 832,722 shares of the company’s stock worth $5,263,000 after buying an additional 132,970 shares in the last quarter. Finally, Wells Fargo & Company MN increased its position in Cerus Corp. by 25.9% in the fourth quarter. Wells Fargo & Company MN now owns 4,901,666 shares of the company’s stock worth $30,979,000 after buying an additional 1,007,430 shares in the last quarter.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.